Starting in 2007, we discussed the huge payments made by four medical device companies to orthopedic surgeons and medical organizations related to the use of hip and knee prostheses. (See post here with links backward.) Payments, in the millions of dollars per year range, went to surgeons including noted academics, and leaders of the main orthopedic physicians' society. Payments went to medical schools, teaching hospitals, and professional societies. Many of these financial relationships were not disclosed, and the disclosures that were made rarely indicated the amounts involved.
Now the Wall Street Journal reports millions being paid to spine surgeons by Medtronic in connection with devices used in spinal fusion. See Dr Howard Brody's discussion here on the Hooked: Ethics, Medicine, and Pharma blog, and also Felix Salmon's discussion here on the Felix Salmon blog.
What seems lacking is a clear rationale for any payments, much less for payments of the sizes listed. The WSJ article cited a Medtronic spokesperson, "surgeons' device-development work goes beyond mere consulting when the company deems that they are contributing valuable intellectual property to a product. But that intellectual property doesn't necessarily have to be patented." The reporters found, "search of spine-device patents awarded to the Norton surgeons turned up about a dozen total for Drs. Puno, Johnson, Campbell and Dimar, most owned by companies other than Medtronic. The search turned up no patents for Dr. Glassman." So what intellectual property that was not or could not be patented could be worth millions a year?
Home
»
conflicts of interest
»
medical devices
»
Medtronic
»
spine surgeons
» BLOGSCAN - Medtronic's Multi-Million Dollar Payments to Spine Surgeons
Related Posts
55 of Medtronic's Best Hospital Friends, Including HCA, Settle for $34 Million
03 Jul 20130The case of the over-marketing of Kyphon's kyphoplasty device (look here) just got more complicated,...Read more »
Planned Obsolescence Disguised as Innovation, Oligopoly Disguised as a Free Market, and the Enrichment of Oligarchs
14 Apr 20140The New York Times published another article in its series on the high cost of US health care. ...Read more »
Health Care Corruption, "No Dirty Little Secret," but "An Open Sore" - Lessons from India for the US
01 Jul 20140Health care corruption is widely prevalent around the globe, but remains the great unmentionable.Int...Read more »
Abort, Retry, Fail? - Lancet Avoided Much Recent Unpleasantness in Reporting on New Gates Foundation CEO (Including Her Defense of $55,000 a Year for Bevacizumab)
05 May 20140The April 26, 2014 issue of the prestigious journal Lancet used two full pages and two separate arti...Read more »
American Board of Internal Medicine Quietly Discloses Some Conflicts of Interest
24 Apr 20140We recently discussed the American Board of Internal Medicine's exceedingly weak conflict of interes...Read more »
Đăng ký:
Đăng Nhận xét (Atom)
0 nhận xét:
Đăng nhận xét
Click to see the code!
To insert emoticon you must added at least one space before the code.